Blackstone Group »

Mirati Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $570k 9.7k 58.75

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Energy Transfer Com Ut Ltd Ptn (ET)
Corebridge Finl (CRBG)
Gates Indl Corp Ord Shs (GTES)
FirstEnergy (FE)
Chesapeake Energy Corp (CHK)
Cheniere Energy Com New (LNG)
PG&E Corporation (PCG)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Bumble Com Cl A (BMBL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)

View all positions for Blackstone Group

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics